School of Medicine
Showing 11-19 of 19 Results
-
Kenneth Tran, MD
Clinical Assistant Professor, Surgery - Vascular Surgery
BioDr. Tran is a vascular surgeon in the Vascular and Endovascular Surgery Division at Stanford Health Care. He is also a clinical assistant professor of surgery at the Stanford University School of Medicine.
Dr. Tran graduated with high honors from the University of Virginia School of Engineering in 2011 and earned his medical degree from Stanford University School of Medicine in 2016. He completed his surgical training at Stanford University School of Medicine, culminating in his completion of the Vascular Surgery Integrated Residency at Stanford in 2023. During his residency, Dr. Tran completed a two-year NIH-funded fellowship under the mentorship of Dr. Alison Marsden. This fellowship focused on using computer simulations of blood flow to enhance the treatment of vascular diseases.
Dr. Tran's research pursuits center on expanding the use of computational simulation techniques to understand changes in blood flow after different vascular treatments. He also has a special interest in using customized grafts to repair complex aortic conditions. Dr. Tran studies blood flow and clinical outcomes after treatment with these customized aortic grafts.
He has published his work in numerous prestigious peer-reviewed journals, including the Journal of Vascular Surgery, JAMA Surgery, and the European Journal of Vascular and Endovascular Surgery. He has presented at the podium at numerous national and international conferences. Dr. Tran has also received multiple research awards, including the Vascular and Endovascular Surgery Society’s Medtronic Resident Research Award, the best resident presentation at the Swiss Society for Vascular Diseases, and the Young Researcher Prize at the European Symposium on Vascular Biomaterials. He also co-authored a chapter in the book Complications in Endovascular Surgery.
Dr. Tran’s clinical interests include the entire spectrum of vascular surgery, including but not limited to:
• Traditional and minimally invasive strategies for aortic aneurysm repair
• Traditional, minimally invasive, and hybrid methods for managing peripheral vascular disease
• Management of cerebrovascular disease, including carotid angioplasty/stenting, transcarotid artery revascularization (TCAR), and conventional carotid surgery
• Comprehensive dialysis access creation
• Treatment of venous reflux -
Jennifer Tremmel
Susan P. and Riley P. Bechtel Medical Director and Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Tremmel studies sex differences in cardiovascular disease. Current research projects include evaluating sex differences in coronary pathophysiology, young patients presenting with myocardial infarction, the impact of stress on anginal symptoms, chronic total coronary occlusions, and vascular access site complications.
-
Stephen Tsai
Professor (Research) of Aeronautics and Astronautics, Emeritus
BioProfessor Tsai's research interest is in the development of design methodology of composite materials and structures. As an emerging technology, composite materials offer unique performances for structures that combine light weight with durability. Keys to the successful utilization of composite materials are predictability in performance and cost effective design of anisotropic, laminated structures. Current emphasis is placed on the understanding of failure modes, and computer simulation for design and cost estimation.
-
Philip S. Tsao, PhD
Professor (Research) of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsOur primary interests are in the molecular underpinnings of vascular disease as well as assessing disease risk. In addition to targeted investigation of specific signaling molecules, we utilize global genomic analysis to identify gene expression networks and regulatory units. We are particularly interested in the role of microRNAs in gene expression pathways associated with disease.
-
Jason V. Tso, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Tso is a board-certified cardiologist with the Sports Cardiology Program and the Center for Inherited Cardiovascular Disease. He serves as medical director of the Sports Cardiology Program and is a clinical assistant professor in the Division of Cardiovascular Medicine at Stanford University School of Medicine.
As a noninvasive cardiologist with clinical expertise in sports cardiology, Dr. Tso specializes in treating physically active patients. He cares for recreational weekend warriors, elite and professional athletes, and all those in between.
He has experience caring for athletes from professional sports teams and multiple National Collegiate Athletic Association (NCAA) Division I universities. Dr. Tso currently performs cardiac screening and consultations for Bay Area professional sports teams and the NCAA Division I athletes of Stanford University Athletics.
Dr. Tso’s research interests include cardiovascular health and adaptation in athletes. He has spent years studying American-style football players and Masters endurance athletes. He has presented his research at multiple national meetings, including the American College of Cardiology Scientific Sessions, American Heart Association Scientific Sessions, and the national meeting of the Heart Failure Society of America.
Dr. Tso’s research has been published in multiple peer-reviewed journals, including the Journal of the American Heart Association, the European Journal of Preventive Cardiology, and the British Journal of Sports Medicine. He also regularly serves as a reviewer for several cardiology and sports medicine journals. -
Minang (Mintu) Turakhia
Professor of Medicine (Cardiovascular Medicine)
On Leave from 05/23/2022 To 05/22/2024Current Research and Scholarly InterestsDr. Turakhia has an active clinical research program, with funding from AHA, VA, NIH, the medical device industry, and foundations. His research program aims to improve the treatment of heart rhythm disorders, with an emphasis on atrial fibrillation, by evaluating quality and variation of care, comparative and cost-effectiveness of therapies, and risk prediction. Dr. Turakhia has extensive expertise in using large administrative and claims databases for this work. His TREAT-AF retrospective study of over 500,000 patients with newly-diagnosed AF is the largest known research cohort of AF patients. He has served as study PI or chairman of several prominent single- and multicenter trials in atrial fibrillation, investigational devices for electrophysiology procedures, digital health interventions, and sensor technologies.
His other research interests include technology assessment of new device-based therapies and the impact of changing health policy and reform on the delivery of arrhythmia care. Dr. Turakhia is a Fellow of the American Heart Association, American College of Cardiology, and Heart Rhythm Society.
